GW Pharmaceuticals PLC GWPH:NASDAQ

Last Price$165.46NASDAQ Previous Close - Last Trade as of 4:00PM ET 7/19/19

Today's Change-0.55(0.33%)
Bid (Size)$165.45 (1)
Ask (Size)$168.00 (4)
Day Low / High$164.07 - 167.99
Volume294.0 K

Read more news Recent News

European ADRs Move Lower in Wednesday Trading
11:06AM ET 7/17/2019 MT Newswires

American depositary receipts of European stocks were trading 0.73% lower at 1,044.50 on the BNY Mellon Europe Select ADR Index on Wednesday. In continental...

ADR Top % Movers in Pre-Market Trading
6:18AM ET 7/17/2019 MT Newswires

ADR Top % Movers in Pre-Market Trading Gainers STM +1.4% BBL +0.7% RIO +0.6% GWPH +0.5% GSK +0.2% TEVA +0.2% Losers VOD -0.7% NOK -0.6% SAN -0.4% BBVA...

ADR Top % Movers in Pre-Market Trading
6:30AM ET 7/16/2019 MT Newswires

ADR Top % Movers in Pre-Market Trading Gainers NOK +1.4% GSK +1.2% BBVA +0.7% GWPH +0.2% Losers VOD -1.9% TEVA -1.4% RIO -1.2% BP -0.3% CUK -0.3% BBL...

European ADRs Move Lower in Monday Trading
10:33AM ET 7/15/2019 MT Newswires

American Depositary Receipts of European stocks were trading 0.28% lower at 1,054.26 on the BNY Mellon Europe Select ADR Index on Monday. In continental...

Company Profile

Business DescriptionGW Pharmaceuticals Plc is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It offers its lead cannabinoid product, Epidiolex oral solution CV, a pharmaceutical formulation of cannabidiol (CBD) focusing on the treatment of seizures associated with tuberous sclerosis complex. The company was founded by Geoffrey William Guy and Brian Whittle in 1998 and is headquartered in Cambridge, the United Kingdom. View company web site for more details
AddressSovereign House
Cambridge, Cambridgeshire CB24 9BZ
Number of Employees801
Recent SEC Filing07/11/20194
Chief Executive Officer & Executive DirectorJustin D. Gover
Chief Operating OfficerChristopher John Tovey
CFO & Principal Accounting OfficerScott M. Giacobello
Chief Medical OfficerVolker Knappertz

Company Highlights

Price Open$167.36
Previous Close$166.01
52 Week Range$90.14 - 196.00
Market Capitalization$5.1 B
Shares Outstanding30.7 M
SectorHealth Technology
IndustryPharmaceuticals: Other
Next Earnings Announcement08/06/2019

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$7.80
Beta vs. S&P 500N/A
Revenue$15.5 M
Net Profit Margin-447.16%
Return on Equity-40.84%

Analyst Ratings as of 07/12/2019

Consensus RecommendationConsensus Icon
Powered by Factset